Form 4: McKesson Director Bradley Lerman Receives 301 Shares via RSU Grant

Sentiment:

Insider Transaction Report


McKesson Corporation's Director, Bradley E. Lerman, acquired 301 shares of common stock through an immediate vesting of Restricted Stock Units under the company's 2022 Stock Plan.

Summary

  • Bradley E. Lerman, a Director of McKesson Corp (MCK), acquired 301 shares of common stock.
  • The acquisition occurred on July 30, 2025.
  • The shares were acquired at a price of $0, indicating a grant rather than a cash purchase.
  • The shares were granted as Restricted Stock Units (RSUs) pursuant to an automatic annual grant under the 2022 Stock Plan.
  • The RSUs vested immediately, and Mr. Lerman elected to receive the underlying shares upon grant.
  • Following this transaction, Mr. Lerman directly beneficially owns 301 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. It's a routine compensation event, indicating continued alignment of director interests with the company, but does not provide new operational or financial insights.

Positives

  • Director Bradley E. Lerman received 301 shares of common stock, aligning his interests with shareholders.
  • The grant was made under the company's 2022 Stock Plan, indicating a structured and ongoing compensation program.

Negatives

  • No specific negative information is present in this routine compensation filing.

Risks

  • No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of insider equity compensation, common across all industries, including the healthcare distribution and technology sector where McKesson operates. Such grants are standard practice for aligning executive and director interests with shareholder value.

Comparison to Industry Standards

  • The grant of Restricted Stock Units (RSUs) to a director is a common form of equity compensation in large publicly traded companies, including those in the healthcare sector like Cardinal Health (CAH) or AmerisourceBergen (ABC).
  • The immediate vesting and election to receive shares upon grant are typical for certain types of director compensation designed to provide immediate equity ownership and align interests without a lengthy vesting period, consistent with practices at comparable firms.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation DisclosureDisclosure of an equity grant (301 common shares via RSU) to Director Bradley E. Lerman under the 2022 Stock Plan, reflecting standard director compensation practices.07/30/2025Aligns director's financial interests with shareholder value; part of routine corporate governance and compensation structure.

Stakeholder Impact

  • Shareholders: Director's interests are further aligned with shareholders through equity ownership.
  • Employees: No direct impact on general employees mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

  • The filing does not specify any future actions, events, or milestones for the company or the reporting person beyond the immediate share acquisition.

Key Dates

DateDescription
07/30/2025Date of earliest transaction (acquisition of common stock)
07/31/2025Signature date of the reporting person's attorney-in-fact

Keywords

McKesson, MCK, Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Stock Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.